Here’s what we know about the robot so far:
1. Johnson & Johnson leaders first announced plans for the spine robot at the 2022 Wells Fargo Healthcare Conference.
2. Velys Spine earned FDA 510(k) clearance in August. It was developed in partnership with eCential Robotics.
3. Velys Spine is a dual-use robotics and standalone navigation platform. It has pathology-specific workflows and is compatible with DePuy Synthes’ portfolio of spine implants.
4. The robot is indicated for planning and instrumenting spinal fusion procedures in the cervical, thoracolumbar and sacroiliac spine.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
